Eko Foundation Analysis Software with Transformers (EFAST) vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

EFAST by Eko Health is designed for early detection and screening of structural murmurs and atrial fibrillation during routine clinical exams, suitable for a broad range of clinicians. In contrast, Volta Medical's VX1 is an interventional tool specifically for cardiac electrophysiologists, providing real-time AI guidance during complex atrial fibrillation and atrial tachycardia ablation procedures. The choice between them depends on whether the need is for diagnostic screening in general practice or specialized procedural assistance in an EP lab.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered cardiac screening and early detection during routine patient examinations. This tool is ideal for clinicians in primary care or general cardiology seeking to quickly identify structural murmurs and atrial fibrillation at the point of care using a digital stethoscope, facilitating timely referrals and interventions.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose VX1 if…

Choose VX1 if you are a cardiac electrophysiologist performing atrial fibrillation or atrial tachycardia ablation procedures and require real-time AI assistance to identify dispersed electrograms. This software is specifically designed to integrate with existing EP lab systems to enhance procedural guidance, reduce variability, and potentially improve ablation outcomes.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) VX1
Pricing Subscription-based, contact for details Contact for pricing
Deployment Unknown Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST is designed for integration into routine clinical exams using a digital stethoscope, offering real-time analysis, enhanced audio, and EMR integration for a broad range of clinicians. VX1, while real-time, operates within the highly specialized and complex environment of EP lab ablation procedures, requiring integration with existing mapping systems, which implies a more specialized user base and setup.

Clinical Value

Tie

Both tools are FDA-cleared and offer significant clinical value in their respective domains. EFAST provides high sensitivity and specificity for early detection of structural murmurs and AFib in routine exams. VX1 aims to improve the efficacy and standardize outcomes during complex AFib and atrial tachycardia ablation procedures, addressing critical needs in specialized care.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers more transparency regarding its pricing model, stating it is subscription-based with a yearly Eko+ membership and a free trial, and even provides an approximate daily cost for its stethoscope technology. VX1 only states 'contact for pricing,' offering no public details on its cost structure.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare, alongside cloud-based deployment and EMR integration. VX1 does not explicitly state HIPAA compliance or BAA availability in the provided facts, which is a significant gap for enterprise readiness.

Innovation

Tie

Both tools demonstrate significant innovation by applying AI to real-time cardiac diagnostics. EFAST innovates by making advanced cardiac screening accessible during routine auscultation, potentially broadening early detection. VX1 innovates by using AI to analyze complex 3D anatomical and electrical maps to guide highly specialized ablation procedures, improving precision in a niche area.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health (Tool A) provides a comprehensive Help Center with user manuals, FAQs, and multiple direct contact options including live Q&A sessions, phone calls, and support tickets. Volta Medical (Tool B) offers user manuals and contact information, but its overall support resources appear less organized and extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) VX1
Primary AI Functionality Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation. Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Target Specialties Cardiology, Family Medicine, Internal Medicine Cardiology
Specific AI Detection/Guidance AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity). AI-guided real-time identification of dispersed electrograms (EGMs); Provides cycle length estimation from electrograms; Booster mode for increased sensitivity during AT or slow AF.
Integration/Compatibility Seamless integration with Eko digital stethoscopes (e.g., CORE 500); EMR integration. Compatible with most EP recording, 3D navigation systems, and mapping catheters.
Clinical Context Provides real-time, actionable cardiac insights during routine exams; Real-time AI analysis during auscultation. Assists during AFib and atrial tachycardia ablation procedures; Analyzes 3D anatomical and electrical maps of human atria.

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and VX1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams, providing real-time cardiac insights. VX1 by Volta Medical is an AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
EFAST is intended for a broader range of specialties including Cardiology, Family Medicine, and Internal Medicine. VX1 is specifically designed for cardiac electrophysiologists within Cardiology.
EFAST is a cloud-based Software as a Medical Device (SaMD) that integrates seamlessly with Eko digital stethoscopes and offers EMR integration for streamlined documentation. VX1 is software that integrates with existing electrophysiology (EP) lab mapping and recording systems, and is compatible with most EP recording, 3D navigation systems, and mapping catheters.
EFAST provides AI-powered detection of structural murmurs with 93% sensitivity and 91% specificity, and atrial fibrillation detection with 95% sensitivity and 94% specificity during auscultation. VX1 offers AI-guided real-time identification of dispersed electrograms and analyzes 3D anatomical and electrical maps of human atria during ablation procedures, also providing cycle length estimation from electrograms.

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.